{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:31:14Z","timestamp":1790958674949,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2017-06962"],"award-info":[{"award-number":["RGPIN-2017-06962"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-159711"],"award-info":[{"award-number":["PJT-159711"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["16GRU3711"],"award-info":[{"award-number":["16GRU3711"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK076169"],"award-info":[{"award-number":["DK076169"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bbi.2021.11.005","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T21:38:24Z","timestamp":1637357904000},"page":"55-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis"],"prefix":"10.1016","volume":"100","author":[{"given":"Natasha Z.","family":"Anita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Zebarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Yuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinie","family":"Shahrul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Pakosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Swardfager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2021.11.005_b0005","doi-asserted-by":"crossref","unstructured":"Profenno LA, Porsteinsson AP, Faraone S V. Meta-Analysis of Alzheimer\u2019s Disease Risk with Obesity, Diabetes, and Related Disorders. Biol Psychiatry [Internet]. 2010;67(6):505\u201312. Available from: 10.1016\/j.biopsych.2009.02.013.","DOI":"10.1016\/j.biopsych.2009.02.013"},{"issue":"4","key":"10.1016\/j.bbi.2021.11.005_b0010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2337\/dc11-1855","article-title":"Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: Post hoc epidemiologic analysis of the ACCORD trial","volume":"35","author":"Punthakee","year":"2012","journal-title":"Diabetes Care."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.005_b0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2337\/dc16-1229","article-title":"Cognitive dysfunction in older adults with diabetes: What a clinician needs to know","volume":"40","author":"Munshi","year":"2017","journal-title":"Diabetes Care."},{"issue":"March","key":"10.1016\/j.bbi.2021.11.005_b0020","first-page":"1","article-title":"A review and hypothesized model of the mechanisms that underpin the relationship between inflammation and cognition in the elderly","volume":"11","author":"Fard","year":"2019","journal-title":"Front Aging Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"Risk Factors and Cardiovascular Disease Prevention The Role of Inflammation in Diabetes : Current Concepts and Future Perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol Rev."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.005_b0030","doi-asserted-by":"crossref","DOI":"10.4155\/fso.15.23","article-title":"Brain signaling systems in the Type 2 diabetes and metabolic syndrome: Promising target to treat and prevent these diseases","volume":"1","author":"Shpakov","year":"2015","journal-title":"Futur Sci OA."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.005_b0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4103\/2230-8210.183480","article-title":"Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?","volume":"20","author":"Chawla","year":"2016","journal-title":"Indian J Endocrinol Metab."},{"key":"10.1016\/j.bbi.2021.11.005_b0040","doi-asserted-by":"crossref","unstructured":"Swardfager W, Lanctt K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry [Internet]. 2010;68(10):930\u201341. Available from: 10.1016\/j.biopsych.2010.06.012.","DOI":"10.1016\/j.biopsych.2010.06.012"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-04515-w","article-title":"Plasma homocysteine and cerebral small vessel disease as possible mediators between kidney and cognitive functions in patients with diabetes mellitus","volume":"7","author":"Sonoda","year":"2017","journal-title":"Sci Rep."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.005_b0050","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3233\/JAD-170162","article-title":"Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment","volume":"58","author":"Tian","year":"2017","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0055","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JAD-200095","article-title":"A New Neurovascular Panel Discriminates between Patients with Type 2 Diabetes Mellitus with Cognitive Impairment and Cognitive Impairment Alone","volume":"75","author":"Zhang","year":"2020","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"6","key":"10.1016\/j.bbi.2021.11.005_b0060","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1161\/HYPERTENSIONAHA.119.14307","article-title":"Associations of Arterial Stiffness with Cognitive Performance, and the Role of Microvascular Dysfunction: The Maastricht Study","volume":"75","author":"Rensma","year":"2020","journal-title":"Hypertension."},{"key":"10.1016\/j.bbi.2021.11.005_b0065","doi-asserted-by":"crossref","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339. 2009; Available from 10.1136\/bmj.b2700.","DOI":"10.1136\/bmj.b2700"},{"key":"10.1016\/j.bbi.2021.11.005_b0070","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.2147\/DMSO.S271160","article-title":"Association Between Inflammatory Biomarkers and Cognitive Dysfunction Analyzed by MRI in Diabetes Patients","volume":"13","author":"Yang","year":"2020","journal-title":"Diabetes Metab Syndr Obes."},{"key":"10.1016\/j.bbi.2021.11.005_b0075","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2019"},{"key":"10.1016\/j.bbi.2021.11.005_b0080","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013. Available from http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.005_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting Meta-Analyses in R with the metafor Package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"Journal of Statistical Software"},{"key":"10.1016\/j.bbi.2021.11.005_b0090","series-title":"ggplot2: Elegant Graphics for Data Analysis, Springer-Verlag","author":"Wickham","year":"2016"},{"issue":"13","key":"10.1016\/j.bbi.2021.11.005_b0095","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1177\/1535370217711440","article-title":"Ameliorating effect of anti-Alzheimer\u2019s drugs on the bidirectional association between type 2 diabetes mellitus and Alzheimer\u2019s disease","volume":"242","author":"Ahmed","year":"2017","journal-title":"Exp Biol Med."},{"issue":"10","key":"10.1016\/j.bbi.2021.11.005_b0100","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/ggi.12602","article-title":"Inflammatory hypothesis as a link between Alzheimer\u2019s disease and diabetes mellitus","volume":"16","author":"Bozluolcay","year":"2016","journal-title":"Geriatr Gerontol Int."},{"key":"10.1016\/j.bbi.2021.11.005_b0105","doi-asserted-by":"crossref","unstructured":"Cai R, Huang R, Han J, Sun H, Sun J, Xia W, et al. Lipoprotein-associated Phospholipase A2 Is Associated with Risk of Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes. Sci Rep [Internet]. 2017;7(1):1\u20139. Available from: 10.1038\/s41598-017-12515-z.","DOI":"10.1038\/s41598-017-12515-z"},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0110","first-page":"161","article-title":"Indicatori ai disfunc\u0163iei cognitive la pacien\u0163ii cu diabet zaharat tip 2","volume":"24","author":"Cernea","year":"2016","journal-title":"Rev Rom Med Lab."},{"issue":"12","key":"10.1016\/j.bbi.2021.11.005_b0115","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.2337\/dc11-0958","article-title":"Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment","volume":"34","author":"Chen","year":"2011","journal-title":"Diabetes Care."},{"key":"10.1016\/j.bbi.2021.11.005_b0120","doi-asserted-by":"crossref","unstructured":"Chen RH, Jiang XZ, Zhao XH, Qin YL, Gu Z, Gu PL, et al. Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: A cross-section study. Ann Endocrinol (Paris) [Internet]. 2012;73(3):208\u201312. Available from: 10.1016\/j.ando.2012.04.009.","DOI":"10.1016\/j.ando.2012.04.009"},{"key":"10.1016\/j.bbi.2021.11.005_b0125","doi-asserted-by":"crossref","unstructured":"Damanik J, Mayza A, Rachman A, Sauriasari R, Kristanti M, Agustina PS, et al. Association between serum homocysteine level and cognitive function in middle-aged type 2 diabetes mellitus patients. PLoS One [Internet]. 2019;14(11):1\u201311. Available from: 10.1371\/journal.pone.0224611.","DOI":"10.1371\/journal.pone.0224611"},{"issue":"1-2","key":"10.1016\/j.bbi.2021.11.005_b0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cccn.2005.03.049","article-title":"Homocysteine, vitamin B 12 and folate in Alzheimer\u2019s and vascular dementias: The paradoxical effect of the superimposed type II diabetes mellitus condition","volume":"359","author":"Dom\u00ednguez","year":"2005","journal-title":"Clin Chim Acta."},{"issue":"12","key":"10.1016\/j.bbi.2021.11.005_b0135","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2174\/1567205016666190827112546","article-title":"Strong Association of Serum GSK-3\u03b2\/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients","volume":"16","author":"Du","year":"2020","journal-title":"Curr Alzheimer Res."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.005_b0140","doi-asserted-by":"crossref","first-page":"e0120433","DOI":"10.1371\/journal.pone.0120433","article-title":"Serum levels of inflammatory markers in depressed elderly patients with diabetes and mild cognitive impairment","volume":"10","author":"Gorska-Ciebiada","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.bbi.2021.11.005_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/826180","article-title":"Serum Soluble Adhesion Molecules and Markers of Systemic Inflammation in Elderly Diabetic Patients with Mild Cognitive Impairment and Depressive Symptoms","volume":"2015","author":"Gorska-Ciebiada","year":"2015","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.bbi.2021.11.005_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2015.00209","article-title":"C-reactive protein, advanced glycation end products, and their receptor in type 2 diabetic, elderly patients with mild cognitive impairment","volume":"7","author":"Gorska-Ciebiada","year":"2015","journal-title":"Front Aging Neurosci."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11011-015-9739-0","article-title":"Adiponectin, leptin and IL-1 \u03b2 in elderly diabetic patients with mild cognitive impairment","volume":"31","author":"Gorska-Ciebiada","year":"2016","journal-title":"Metab Brain Dis."},{"key":"10.1016\/j.bbi.2021.11.005_b0160","doi-asserted-by":"crossref","unstructured":"Gorska-Ciebiada M, Ciebiada M. Association of hsCRP and vitamin D levels with mild cognitive impairment in elderly type 2 diabetic patients. Exp Gerontol [Internet]. 2020;135(November 2019):110926. Available from: 10.1016\/j.exger.2020.110926.","DOI":"10.1016\/j.exger.2020.110926"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-019-0431-y","article-title":"Association between plasma adipsin level and mild cognitive impairment in Chinese patients with type 2 diabetes: A cross-sectional study","volume":"19","author":"Guo","year":"2019","journal-title":"BMC Endocr Disord."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.005_b0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1573399814666180423113341","article-title":"Role of Inflammatory Markers in Elderly Type 2 Diabetic Patients with Mild Cognitive Impairment","volume":"15","author":"Hosny","year":"2019","journal-title":"Curr Diabetes Rev."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0175","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/1566524019666190819160403","article-title":"Decrease in Serum Levels of Adiponectin and Increase in 8-OHdG: a Culprit for Cognitive Impairment in the Elderly Patients with Type 2 Diabetes","volume":"20","author":"Huang","year":"2019","journal-title":"Curr Mol Med."},{"issue":"23","key":"10.1016\/j.bbi.2021.11.005_b0180","first-page":"5471","article-title":"Analysis of correlation between the mild cognitive impairment (MCI) and level of adiponectin in elderly patients with type 2 diabetes mellitus (T2DM)","volume":"21","author":"Liu","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"10.1016\/j.bbi.2021.11.005_b0185","doi-asserted-by":"crossref","unstructured":"Moulton CD, Stewart R, Amiel SA, Laake JP, Ismail K. Factors associated with cognitive impairment in patients with newly diagnosed type 2 diabetes: a cross-sectional study. Aging Ment Heal [Internet]. 2016;20(8):840\u20137. Available from: 10.1080\/13607863.2015.1040723.","DOI":"10.1080\/13607863.2015.1040723"},{"issue":"20","key":"10.1016\/j.bbi.2021.11.005_b0190","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4239\/wjd.v7.i20.615","article-title":"Brain-derived neurotrophic factor plasma levels and premature cognitive impairment\/dementia in type 2 diabetes","volume":"7","author":"Murillo Ort\u00edz","year":"2016","journal-title":"World J Diabetes."},{"key":"10.1016\/j.bbi.2021.11.005_b0195","doi-asserted-by":"crossref","unstructured":"Ragy MM, Kamal NN. Linking senile dementia to type 2 diabetes: role of oxidative stress markers, C-reactive protein and tumor necrosis factor-\u03b1. Neurol Res [Internet]. 2017;39(7):587\u201395. Available from: 10.1080\/01616412.2017.1312773.","DOI":"10.1080\/01616412.2017.1312773"},{"issue":"7-8","key":"10.1016\/j.bbi.2021.11.005_b0200","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/1533317519860334","article-title":"Decreased Levels of Serum IGF-1 and Vitamin D Are Associated With Cognitive Impairment in Patients With Type 2 Diabetes","volume":"34","author":"Rui-hua","year":"2019","journal-title":"Am J Alzheimers Dis Other Demen."},{"key":"10.1016\/j.bbi.2021.11.005_b0205","doi-asserted-by":"crossref","unstructured":"Sanke H, Mita T, Yoshii H, Yokota A, Yamashiro K, Ingaki N, et al. Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus. Diabetes Res Clin Pract [Internet]. 2014;106(3):465\u201373. Available from: 10.1016\/j.diabres.2014.09.039.","DOI":"10.1016\/j.diabres.2014.09.039"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/JAD-160053","article-title":"Cholesteryl ester transfer protein intimately involved in dyslipidemia-related susceptibility to cognitive deficits in type 2 diabetic patients","volume":"54","author":"Sun","year":"2016","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.005_b0215","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000493275","article-title":"Reduced serum levels of brain-derived neurotrophic factor are related to mild cognitive impairment in Chinese patients with type 2 diabetes mellitus","volume":"73","author":"Sun","year":"2018","journal-title":"Ann Nutr Metab."},{"key":"10.1016\/j.bbi.2021.11.005_b0220","first-page":"1","article-title":"Risk Factors for Cognitive Impairment in Patients with Type 2 Diabetes","volume":"2020","author":"Sun","year":"2020","journal-title":"J Diabetes Res."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0225","first-page":"31","article-title":"Tip 2 diabetes mellitus\u2019lu hastalarda g\u00f6r\u00fclen bili\u015fsel bozukluk ile beta amiloid\u2019in plazma d\u00fczeyleri, ins\u00fclin-par\u00e7alayan enzim ve ileri glikozilasyon son \u00fcr\u00fcnlerinin ili\u015fkisi","volume":"5","author":"Syafrita","year":"2017","journal-title":"Turkish J Immunol."},{"key":"10.1016\/j.bbi.2021.11.005_b0230","doi-asserted-by":"crossref","unstructured":"Tian S, Huang R, Han J, Cai R, Guo D, Lin H, et al. Increased plasma Interleukin-1\u03b2 level is associated with memory deficits in type 2 diabetic patients with mild cognitive impairment. Psychoneuroendocrinology [Internet]. 2018;96(87):148\u201354. Available from: 10.1016\/j.psyneuen.2018.06.014.","DOI":"10.1016\/j.psyneuen.2018.06.014"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0235","doi-asserted-by":"crossref","first-page":"e0145521","DOI":"10.1371\/journal.pone.0145521","article-title":"RAGE and AGEs in mild cognitive impairment of diabetic patients: A cross-sectional study","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0240","first-page":"1267","article-title":"Glycogen synthase kinase-3\u03b2 (Gsk-3\u03b2) rs334558 polymorphism is not associated with mild cognitive impairment in chinese han type 2 diabetic patients","volume":"10","author":"Wang","year":"2017","journal-title":"Int J Clin Exp Med."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0245","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3233\/JAD-171038","article-title":"Association between Plasma Levels of PAI-1, tPA\/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus","volume":"63","author":"Wang","year":"2018","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.005_b0250","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3233\/JAD-200074","article-title":"High Plasma Resistin Levels Portend the Insulin Resistance-Associated Susceptibility to Early Cognitive Decline in Patients with Type 2 Diabetes Mellitus","volume":"75","author":"Wang","year":"2020","journal-title":"J Alzheimer\u2019s Dis."},{"key":"10.1016\/j.bbi.2021.11.005_b0255","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00132","article-title":"Low plasma leptin and high soluble leptin receptor levels are associated with mild cognitive impairment in type 2 diabetic patients","volume":"10","author":"Yin","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.bbi.2021.11.005_b0260","unstructured":"Yu Y, Mingjiao W, Yang X, Sui M, Zhang T, Liang J, et al. Association entre m\u00e9thylation de l\u2019ADN de la r\u00e9gion flanquante 5\u2032 de SORL1et d\u00e9ficience cognitive l\u00e9g\u00e8re dans le cadre d\u2019un diab\u00e8te de type 2. Ann Endocrinol (Paris) [Internet]. 2016;77(6):625\u201332. Available from: 10.1016\/j.ando.2016.02.008."},{"key":"10.1016\/j.bbi.2021.11.005_b0265","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2147\/DMSO.S249126","article-title":"High serum neuron-specific enolase level is associated with mild cognitive impairment in patients with diabetic retinopathy","volume":"13","author":"Yu","year":"2020","journal-title":"Diabetes, Metab Syndr Obes Targets Ther."},{"issue":"6","key":"10.1016\/j.bbi.2021.11.005_b0270","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/1567205013666161201200722","article-title":"Plasma Phospholipids are Associated with Mild Cognitive Impairment in Type 2 Diabetic Patients","volume":"14","author":"Zhang","year":"2017","journal-title":"Curr Alzheimer Res."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0275","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-019-0402-3","article-title":"Relationship between inflammatory markers and mild cognitive impairment in Chinese patients with type 2 diabetes: a case-control study","volume":"19","author":"Zheng","year":"2019","journal-title":"BMC Endocr Disord."},{"key":"10.1016\/j.bbi.2021.11.005_b0280","first-page":"105","article-title":"105\u2013112 p","volume":"87","author":"Zheng","year":"2018","journal-title":"Available from"},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0285","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3164\/jcbn.13-89","article-title":"Relationship between blood levels of methyl donor and folate and mild cognitive impairment in Chinese patients with type 2 diabetes: a case-control study","volume":"54","author":"Zheng","year":"2014","journal-title":"J Clin Biochem Nutr."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.005_b0290","doi-asserted-by":"crossref","first-page":"236","DOI":"10.14336\/AD.2014.1004","article-title":"Clinical characteristics for the relationship between type-2 diabetes mellitus and cognitive impairment: A cross-sectional study","volume":"6","author":"Zhou","year":"2015","journal-title":"Aging Dis."},{"issue":"5","key":"10.1016\/j.bbi.2021.11.005_b0295","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11910-007-0058-7","article-title":"Type 2 diabetes and risk of cognitive impairment and dementia","volume":"7","author":"Whitmer","year":"2007","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0891988708328216","article-title":"Association between cytokines and cerebral MRI changes in the aging brain","volume":"22","author":"Baune","year":"2009","journal-title":"J Geriatr Psychiatry Neurol."},{"issue":"7","key":"10.1016\/j.bbi.2021.11.005_b0305","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1523\/JNEUROSCI.2830-13.2014","article-title":"Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain","volume":"34","author":"Campbell","year":"2014","journal-title":"J Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.005_b0310","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/ijms21030841","article-title":"Brain-derived neurotrophic factor and diabetes","volume":"21","author":"Rozanska","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"10","key":"10.1016\/j.bbi.2021.11.005_b0315","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.2337\/db05-1404","article-title":"Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase","volume":"55","author":"Carey","year":"2006","journal-title":"Diabetes."},{"issue":"5","key":"10.1016\/j.bbi.2021.11.005_b0320","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.2337\/db08-0775","article-title":"Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-\u03b1 expression","volume":"58","author":"Yuen","year":"2009","journal-title":"Diabetes."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0325","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1096\/fj.09-141754","article-title":"Massive gliosis induced by interleukin-6 suppresses A\u03b2 deposition in vivo: evidence against inflammation as a driving force for amyloid deposition","volume":"24","author":"Chakrabarty","year":"2010","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0330","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.bbi.2021.11.005_b0335","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000346362","article-title":"Peripheral inflammation and cognitive aging","volume":"28","author":"Lim","year":"2013","journal-title":"Inflamm Psychiatry."},{"key":"10.1016\/j.bbi.2021.11.005_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-6-1","article-title":"Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia","volume":"6","author":"Sondag","year":"2009","journal-title":"J Neuroinflammation."},{"issue":"12","key":"10.1016\/j.bbi.2021.11.005_b0345","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.3390\/ijms18122563","article-title":"Cellular and oxidative mechanisms associated with interleukin-6 signaling in the vasculature","volume":"18","author":"Didion","year":"2017","journal-title":"Int J Mol Sci."},{"issue":"18","key":"10.1016\/j.bbi.2021.11.005_b0350","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.116.023446","article-title":"Prediabetes and Type 2 Diabetes Are Associated with Generalized Microvascular Dysfunction: The Maastricht Study","volume":"134","author":"S\u00f6rensen","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.bbi.2021.11.005_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/609202","article-title":"Vascular pathology and blood-brain barrier disruption in cognitive and psychiatric complications of type 2 diabetes mellitus","volume":"2011","author":"Serlin","year":"2011","journal-title":"Cardiovasc Psychiatry Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0360","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.bbi.2021.11.005_b0365","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0370","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clim.2005.08.004","article-title":"C-reactive protein: Ligands, receptors and role in inflammation","volume":"117","author":"Marnell","year":"2005","journal-title":"Clin Immunol."},{"key":"10.1016\/j.bbi.2021.11.005_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/120540","article-title":"Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults","volume":"2012","author":"Eagan","year":"2012","journal-title":"Cardiovasc Psychiatry Neurol."},{"issue":"5","key":"10.1016\/j.bbi.2021.11.005_b0380","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1159\/000343302","article-title":"C-reactive protein increases BBB permeability: Implications for obesity and neuroinfammation","volume":"30","author":"Hsuchou","year":"2012","journal-title":"Cell Physiol Biochem."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0385","first-page":"125","article-title":"Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview","volume":"2","author":"Prasad","year":"2014","journal-title":"J Pharmacovigil."},{"key":"10.1016\/j.bbi.2021.11.005_b0390","doi-asserted-by":"crossref","unstructured":"Hsieh CF, Liu CK, Lee CT, Yu LE, Wang JY. Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation. Sci Rep [Internet]. 2019;9(1):1\u201316. Available from: 10.1038\/s41598-018-37215-0.","DOI":"10.1038\/s41598-018-37215-0"},{"issue":"6","key":"10.1016\/j.bbi.2021.11.005_b0395","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/CIRCULATIONAHA.104.506337","article-title":"C-reactive protein and cerebral small-vessel disease: The Rotterdam scan study","volume":"112","author":"van Dijk","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.bbi.2021.11.005_b0400","doi-asserted-by":"crossref","unstructured":"Krance SH, Wu CY, Zou Y, Mao H, Toufighi S, He X, et al. The complement cascade in Alzheimer\u2019s disease: a systematic review and meta-analysis. Mol Psychiatry. 2019.","DOI":"10.1038\/s41380-019-0536-8"},{"issue":"6","key":"10.1016\/j.bbi.2021.11.005_b0405","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41380-018-0096-3","article-title":"What does plasma CRP tell us about peripheral and central inflammation in depression?","volume":"25","author":"Felger","year":"2020","journal-title":"Mol Psychiatry."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.005_b0410","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00213-009-1499-2","article-title":"Memory deficits and neurochemical changes induced by C-reactive protein in rats: Implication in Alzheimer\u2019s disease","volume":"204","author":"Lin","year":"2009","journal-title":"Psychopharmacology (Berl)."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0415","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1096\/fj.11-0102ufm","article-title":"Alzheimer\u2019s dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy","volume":"25","author":"Marchesi","year":"2011","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.bbi.2021.11.005_b0420","first-page":"e673","article-title":"The effect of white matter hyperintensities on verbal memory","volume":"90","author":"Swardfager","year":"2018","journal-title":"Neurology [Internet]."},{"key":"10.1016\/j.bbi.2021.11.005_b0425","doi-asserted-by":"crossref","unstructured":"Kapasi A, Schneider JA. Vascular contributions to cognitive impairment, clinical Alzheimer\u2019s disease, and dementia in older persons. Biochim Biophys Acta - Mol Basis Dis [Internet]. 2016;1862(5):878\u201386. Available from: 10.1016\/j.bbadis.2015.12.023.","DOI":"10.1016\/j.bbadis.2015.12.023"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.005_b0430","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/JAD-150042","article-title":"Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis","volume":"47","author":"Saleem","year":"2015","journal-title":"J Alzheimer\u2019s Dis."},{"issue":"6","key":"10.1016\/j.bbi.2021.11.005_b0435","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41591-019-0440-4","article-title":"Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1","volume":"25","author":"Yousef","year":"2019","journal-title":"Nat Med."},{"issue":"1-2","key":"10.1016\/j.bbi.2021.11.005_b0440","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neulet.2005.12.064","article-title":"Indices of low-grade chronic inflammation correlate with early cognitive deterioration in an elderly Greek population","volume":"398","author":"Dimopoulos","year":"2006","journal-title":"Neurosci Lett."},{"issue":"May","key":"10.1016\/j.bbi.2021.11.005_b0445","article-title":"Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis","volume":"7","author":"Iturria-Medina","year":"2016","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0450","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48538-x","article-title":"Blockade of \u03b14 integrins reduces leukocyte\u2013endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer\u2019s disease","volume":"9","author":"Pietronigro","year":"2019","journal-title":"Sci Rep."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.005_b0455","first-page":"560","article-title":"Elevated soluble vascular cell adhesion molecule-1 is associated with cerebrovascular resistance and cognitive function","volume":"72","author":"Tchalla","year":"2017","journal-title":"Journals Gerontol - Ser A Biol Sci Med Sci."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-013-0453-1","article-title":"Advanced glycation end products (AGE) and diabetes: Cause, effect, or both?","volume":"14","author":"Vlassara","year":"2014","journal-title":"Curr Diab Rep."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0465","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron."},{"key":"10.1016\/j.bbi.2021.11.005_b0470","doi-asserted-by":"crossref","unstructured":"Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S ichi. Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression. Biochem Biophys Res Commun [Internet]. 2010;391(3):1405\u20138. Available from: 10.1016\/j.bbrc.2009.12.075.","DOI":"10.1016\/j.bbrc.2009.12.075"},{"issue":"4S_Part_8","key":"10.1016\/j.bbi.2021.11.005_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2011.05.839","article-title":"O2\u201301-07: Advanced Glycation Endproduct Level, Diabetes and Accelerated Cognitive Aging","volume":"7","author":"Yaffe","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0480","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jdiacomp.2015.11.025","article-title":"Analysis of advanced glycation end products in the DHS Mind Study","volume":"30","author":"Adams","year":"2016","journal-title":"J Diabetes Complications."},{"key":"10.1016\/j.bbi.2021.11.005_b0485","doi-asserted-by":"crossref","unstructured":"Byun K, Yoo YC, Son M, Lee J, Jeong GB, Park YM, et al. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases. Pharmacol Ther [Internet]. 2017;177:44\u201355. Available from: 10.1016\/j.pharmthera.2017.02.030.","DOI":"10.1016\/j.pharmthera.2017.02.030"},{"issue":"15","key":"10.1016\/j.bbi.2021.11.005_b0490","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1523\/JNEUROSCI.6251-09.2010","article-title":"Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume","volume":"30","author":"Erickson","year":"2010","journal-title":"J Neurosci."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.005_b0495","doi-asserted-by":"crossref","first-page":"e35217","DOI":"10.1371\/journal.pone.0035217","article-title":"Plasma BDNF is associated with age-related white matter atrophy but not with cognitive function in older, non-demented adults","volume":"7","author":"Driscoll","year":"2012","journal-title":"PLoS One."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0500","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0197-4580(93)90087-R","article-title":"BDNF and trkB mRNA expression in the hippocampal formation of aging rats","volume":"14","author":"Lapchak","year":"1993","journal-title":"Neurobiol Aging."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0505","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbi.2005.04.005","article-title":"Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats","volume":"20","author":"Guan","year":"2006","journal-title":"Brain Behav Immun."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20020257","article-title":"Decreased serum brain-derived neurotrophic factor (BDNF) levels in patients with Alzheimer\u2019s disease (AD): A systematic review and meta-analysis","volume":"20","author":"Ng","year":"2019","journal-title":"Int J Mol Sci."},{"issue":"04","key":"10.1016\/j.bbi.2021.11.005_b0520","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1017\/S1461145709991015","article-title":"Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: Correlation with plasma BDNF and psychopathology","volume":"13","author":"Pillai","year":"2010","journal-title":"Int J Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-45976-5","article-title":"Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy","volume":"9","author":"Gejl","year":"2019","journal-title":"Sci Rep."},{"key":"10.1016\/j.bbi.2021.11.005_b0530","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.00217","article-title":"Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer\u2019s Disease: the Receptor for Advanced Glycation End Products (RAGE)","volume":"12","author":"Kong","year":"2020","journal-title":"Front Aging Neurosci."},{"issue":"10","key":"10.1016\/j.bbi.2021.11.005_b0535","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","article-title":"Peripheral inflammatory markers in Alzheimer\u2019s disease: A systematic review and meta-analysis of 175 studies","volume":"88","author":"Lai","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"11","key":"10.1016\/j.bbi.2021.11.005_b0540","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/DMSO.S106797","article-title":"Depression in people with type 2 diabetes: current perspectives","volume":"10","author":"Darwish","year":"2018","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"10","key":"10.1016\/j.bbi.2021.11.005_b0545","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jamapsychiatry.2013.1965","article-title":"Association of Depression With Accelerated Cognitive Decline Among Patients With Type 2 Diabetes in the ACCORD-MIND Trial","volume":"70","author":"Sullivan","year":"2013","journal-title":"JAMA Psychiatry."},{"key":"10.1016\/j.bbi.2021.11.005_b0550","doi-asserted-by":"crossref","first-page":"105448","DOI":"10.1016\/j.psyneuen.2021.105448","article-title":"Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markers","volume":"134","author":"Nguyen","year":"2021","journal-title":"Psychoneuroendocrinology."},{"issue":"5","key":"10.1016\/j.bbi.2021.11.005_b0555","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr Scand."},{"issue":"283","key":"10.1016\/j.bbi.2021.11.005_b0560","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jad.2021.01.039","article-title":"Associations between cognitive function, metabolic factors and depression: A prospective study in Quebec","volume":"15","author":"Ferri","year":"2021","journal-title":"Canada. J Affect Disord."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0565","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00125-020-05301-6","article-title":"Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammation","volume":"64","author":"Carr","year":"2021","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.005_b0570","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3233\/JAD-201462","article-title":"Promoting Successful Cognitive Aging: A Ten-Year Update","volume":"81","author":"Krivanek","year":"2021","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.bbi.2021.11.005_b0575","doi-asserted-by":"crossref","unstructured":"Kantor ED, Lampe JW, Kratz M, White E. Lifestyle factors and inflammation: associations by body mass index. PLoS One. 2013;8(7):e67833. Published 2013 Jul 2.","DOI":"10.1371\/journal.pone.0067833"},{"key":"10.1016\/j.bbi.2021.11.005_b0580","doi-asserted-by":"crossref","unstructured":"Zhang YW, Zhang JQ, Liu C, et al. Memory dysfunction in type 2 diabetes mellitus correlates with reduced hippocampal CA1 and subiculum volumes. Chin Med J (Engl). 2015;128(4):465-471.","DOI":"10.4103\/0366-6999.151082"},{"key":"10.1016\/j.bbi.2021.11.005_b0585","doi-asserted-by":"crossref","unstructured":"Ho N, Sommers MS, Lucki I. Effects of diabetes on hippocampal neurogenesis: links to cognition and depression. Neurosci Biobehav Rev. 2013 Sep;37(8):1346-62. doi: 10.1016\/j.neubiorev.2013.03.010. Epub 2013 May 13. PMID: 23680701; PMCID: PMC3788092.","DOI":"10.1016\/j.neubiorev.2013.03.010"},{"key":"10.1016\/j.bbi.2021.11.005_b0590","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front Cell Neurosci."},{"issue":"7","key":"10.1016\/j.bbi.2021.11.005_b0595","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2337\/dc06-0261","article-title":"Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes","volume":"29","author":"Novak","year":"2006","journal-title":"Diabetes Care."},{"issue":"12","key":"10.1016\/j.bbi.2021.11.005_b0600","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/dme.13800","article-title":"Cognitive functioning and structural brain abnormalities in people with Type 2 diabetes mellitus","volume":"35","author":"Mankovsky","year":"2018","journal-title":"Diabet Med."},{"issue":"11","key":"10.1016\/j.bbi.2021.11.005_b0605","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.2337\/db14-0342","article-title":"White matter integrity disruptions associated with cognitive impairments in type 2 diabetic patients","volume":"63","author":"Zhang","year":"2014","journal-title":"Diabetes."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.005_b0610","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2337\/diabetes.55.04.06.db05-1323","article-title":"Utrecht Diabetic Encephalopathy Study Group. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes","volume":"55","author":"Manschot","year":"2006","journal-title":"Diabetes."},{"issue":"12","key":"10.1016\/j.bbi.2021.11.005_b0615","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.2337\/dc13-0143","article-title":"Brain atrophy in type 2 diabetes: regional distribution and influence on cognition","volume":"36","author":"Moran","year":"2013","journal-title":"Diabetes Care."},{"issue":"11","key":"10.1016\/j.bbi.2021.11.005_b0620","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1212\/WNL.0b013e3181f25f06","article-title":"Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up","volume":"75","author":"van Elderen","year":"2010","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0625","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.dadm.2017.01.001","article-title":"Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease","volume":"7","author":"Zhu","year":"2017","journal-title":"Alzheimers Dement (Amst)."},{"issue":"7","key":"10.1016\/j.bbi.2021.11.005_b0630","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dadm.2016.12.011","article-title":"Peripheral inflammatory markers indicate microstructural damage within periventricular white matter hyperintensities in Alzheimer's disease: A preliminary report","volume":"21","author":"Swardfager","year":"2017","journal-title":"Alzheimers Dement (Amst)."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.005_b0635","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.25396","article-title":"Visceral obesity relates to deep white matter hyperintensities via inflammation","volume":"85","author":"Lampe","year":"2019","journal-title":"Ann Neurol."},{"key":"10.1016\/j.bbi.2021.11.005_b0640","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbi.2021.07.014","article-title":"Peripheral levels of C-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and interleukin-1\u03b2 across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability","volume":"97","author":"Solmi","year":"2021","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.bbi.2021.11.005_b0645","doi-asserted-by":"crossref","unstructured":"Fang X, Kaduce TL, Weintraub NL, Harmon S, Teesch LM, Morisseau C, et al. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. J Biol Chem [Internet]. 2001;276(18):14867\u201374. Available from: 10.1074\/jbc.M011761200.","DOI":"10.1074\/jbc.M011761200"},{"key":"10.1016\/j.bbi.2021.11.005_b0650","doi-asserted-by":"crossref","unstructured":"Fang X, Weintraub NL, McCaw RB, Hu S, Harmon SD, Rice JB, et al. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. Am J Physiol - Hear Circ Physiol. 2004;287(6 56-6):2412\u201320.","DOI":"10.1152\/ajpheart.00527.2004"},{"issue":"5","key":"10.1016\/j.bbi.2021.11.005_b0655","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/dmd.115.063339","article-title":"Brodie Award lecture - Epoxide hydrolases: Drug metabolism to therapeutics for chronic pain","volume":"43","author":"Kodani","year":"2015","journal-title":"Drug Metab Dispos."},{"issue":"9","key":"10.1016\/j.bbi.2021.11.005_b0660","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3390\/metabo9090177","article-title":"Oxylipin profiling of alzheimer\u2019s disease in nondiabetic and type 2 diabetic elderly","volume":"9","author":"Morris","year":"2019","journal-title":"Metabolites."},{"issue":"5","key":"10.1016\/j.bbi.2021.11.005_b0665","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s12975-018-0672-5","article-title":"Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment","volume":"10","author":"Yu","year":"2019","journal-title":"Transl Stroke Res."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.005_b0670","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3233\/JAD-191197","article-title":"Oxidized Products of Omega-6 and Omega-3 Long Chain Fatty Acids Are Associated with Increased White Matter Hyperintensity and Poorer Executive Function Performance in a Cohort of Cognitively Normal Hypertensive Older Adults","volume":"74","author":"Shinto","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.bbi.2021.11.005_b0675","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.prostaglandins.2014.09.003","article-title":"Role of soluble epoxide hydrolase in age-related vascular cognitive decline","volume":"113-115","author":"Nelson","year":"2014","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"6","key":"10.1016\/j.bbi.2021.11.005_b0680","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/dc16-2001","article-title":"Insulin resistance predicts cognitive decline: An 11-year follow-up of a nationally representative adult population sample","volume":"40","author":"Ekblad","year":"2017","journal-title":"Diabetes Care."},{"key":"10.1016\/j.bbi.2021.11.005_b0685","doi-asserted-by":"crossref","unstructured":"Labad J, Price JF, Strachan MWJ, Deary IJ, Seckl JR, Sattar N, et al. Serum leptin and cognitive function in people with Type 2 diabetes. Neurobiol Aging [Internet]. 2012;33(12):2938-2941.e2. Available from: 10.1016\/j.neurobiolaging.2012.02.026.","DOI":"10.1016\/j.neurobiolaging.2012.02.026"},{"issue":"9","key":"10.1016\/j.bbi.2021.11.005_b0690","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.2337\/dc16-2754","article-title":"Hemoglobin A1c variability predicts symptoms of depression in elderly individuals with type 2 diabetes","volume":"40","author":"Ravona-Springer","year":"2017","journal-title":"Diabetes Care."},{"issue":"5","key":"10.1016\/j.bbi.2021.11.005_b0695","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1212\/WNL.0000000000001820","article-title":"Inflammation-associated declines in cerebral vasoreactivity and cognition in type 2 diabetes","volume":"85","author":"Chung","year":"2015","journal-title":"Neurology."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121006012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121006012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:56:58Z","timestamp":1778543818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159121006012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":138,"alternative-id":["S0889159121006012"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2021.11.005","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2021.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}